BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 3998349)

  • 1. Red blood cell abnormalities in Alzheimer disease.
    Blass JP; Hanin I; Barclay L; Kopp U; Reding MJ
    J Am Geriatr Soc; 1985 Jun; 33(6):401-5. PubMed ID: 3998349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated red blood cell/plasma choline ratio in dementia of the Alzheimer type: clinical and polysomnographic correlates.
    Hanin I; Reynolds CF; Kupfer DJ; Kopp U; Taska LS; Hoch CC; Spiker DG; Sewitch DE; Martin D; Marin RS
    Psychiatry Res; 1984 Oct; 13(2):167-73. PubMed ID: 6596584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human red blood cell choline uptake with age and Alzheimer's disease.
    Sherman KA; Gibson GE; Blass JP
    Neurobiol Aging; 1986; 7(3):205-9. PubMed ID: 3724955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Red blood cell/plasma choline ratio in elderly depressed and demented patients.
    Houck PR; Reynolds CF; Kopp U; Hanin I
    Psychiatry Res; 1988 Apr; 24(1):109-16. PubMed ID: 3393614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Red blood cell choline. I: Choline in Alzheimer's disease.
    Greenwald BS; Edasery J; Mohs RC; Shah N; Trigos GG; Davis KL
    Biol Psychiatry; 1985 Apr; 20(4):367-74. PubMed ID: 3978170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in red blood cell choline and lipid-bound choline between patients with Alzheimer disease and control subjects.
    Miller BL; Read S; Tang C; Jenden D
    Neurobiol Aging; 1991; 12(1):61-4. PubMed ID: 2002884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lithium-induced increases in red blood cell choline and memory performance in Alzheimer-type dementia.
    Brinkman SD; Pomara N; Barnett N; Block R; Domino EF; Gershon S
    Biol Psychiatry; 1984 Feb; 19(2):157-64. PubMed ID: 6424733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevation of RBC glycine and choline levels in geriatric patients treated with lithium.
    Pomara N; Banay-Schwartz M; Block R; Stanley M; Gershon S
    Am J Psychiatry; 1983 Jul; 140(7):911-3. PubMed ID: 6407342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decay in plasma lithium and normalization in red blood cell choline following cessation of lithium treatment in two elderly individuals with Alzheimer-type dementia.
    Pomara N; Block R; Domino EF; Gershon S
    Biol Psychiatry; 1984 Jun; 19(6):919-22. PubMed ID: 6430359
    [No Abstract]   [Full Text] [Related]  

  • 10. Red blood cell choline. II: Kinetics in Alzheimer's disease.
    Kanof PD; Greenwald BS; Mohs RC; Davis KL
    Biol Psychiatry; 1985 Apr; 20(4):375-83. PubMed ID: 3978171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluctuations of free choline levels in plasma of Alzheimer patients receiving lecithin: preliminary observations.
    Chuaqui P; Levy R
    Br J Psychiatry; 1982 May; 140():464-9. PubMed ID: 7049290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A dose-ranging study of lecithin in the treatment of primary degenerative dementia (Alzheimer disease).
    Brinkman SD; Pomara N; Goodnick PJ; Barnett N; Domino EF
    J Clin Psychopharmacol; 1982 Aug; 2(4):281-5. PubMed ID: 7119136
    [No Abstract]   [Full Text] [Related]  

  • 13. Abnormal erythrocyte choline and influx in Alzheimer's disease.
    Miller BL; Jenden DJ; Cummings JL; Read S; Rice K; Benson DF
    Life Sci; 1986 Feb; 38(6):485-90. PubMed ID: 3945172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Failure of single-dose lecithin to alter aspects of central cholinergic activity in Alzheimer's disease.
    Pomara N; Domino EF; Yoon H; Brinkman S; Tamminga CA; Gershon S
    J Clin Psychiatry; 1983 Aug; 44(8):293-5. PubMed ID: 6874650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-blind, placebo controlled trial of high-dose lecithin in Alzheimer's disease.
    Little A; Levy R; Chuaqui-Kidd P; Hand D
    J Neurol Neurosurg Psychiatry; 1985 Aug; 48(8):736-42. PubMed ID: 3897460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Red-cell/plasma choline ratio in dementia.
    Barclay LL; Blass JP; Kopp U; Hanin I
    N Engl J Med; 1982 Aug; 307(8):501. PubMed ID: 7099214
    [No Abstract]   [Full Text] [Related]  

  • 17. Biological and neuropsychological characterization of physostigmine responders and nonresponders in Alzheimer's disease.
    Harrell LE; Jope RS; Falgout J; Callaway R; Avery C; Spiers M; Leli D; Morere D; Halsey JH
    J Am Geriatr Soc; 1990 Feb; 38(2):113-22. PubMed ID: 2405043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma alterations in cholinergic and serotonergic systems in early Alzheimer Disease: Diagnosis utility.
    Peña-Bautista C; Flor L; López-Nogueroles M; García L; Ferrer I; Baquero M; Vento M; Cháfer-Pericás C
    Clin Chim Acta; 2020 Jan; 500():233-240. PubMed ID: 31678274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double blind study of lecithin in patients with Alzheimer's disease.
    Fisman M; Merskey H; Helmes E; McCready J; Colhoun EH; Rylett BJ
    Can J Psychiatry; 1981 Oct; 26(6):426-8. PubMed ID: 7028239
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of long-term high dose lecithin on erythrocyte choline transport in Alzheimer patients.
    Uney JB; Jones GM; Rebeiro A; Levy R
    Biol Psychiatry; 1992 Mar; 31(6):630-3. PubMed ID: 1581445
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.